查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1781990

自我監測血糖設備市場（按產品類型、按技術、按檢測地點、按患者類型、按最終用戶、按國家和地區）－2025 年至 2032 年全球產業分析、市場規模、市場佔有率及預測

Self-monitoring Blood Glucose Devices Market, By Product Type, By Technology, By Testing Site, By Patient Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年自我監測血糖設備市場規模價值 197.5201 億美元，2025 年至 2032 年的複合年成長率為 11.53%。

自我監測血糖設備市場-市場動態

糖尿病盛行率上升和技術創新推動自我血糖監測設備需求

糖尿病盛行率的上升，加上科技的快速創新，正推動全球自我血糖監測設備的普及。國際糖尿病聯盟報告稱，全球約有十分之一的成年人患有糖尿病，凸顯了對有效自我照護工具的迫切需求。非侵入式感測器和行動應用程式整合等技術進步，使血糖監測更加便捷和準確。美國疾病管制與預防中心 (CDC) 強調，定期監測血糖可以顯著減少併發症，並改善糖尿病患者的生活品質。此外，印度和巴西等國的政府健康計畫正在透過補貼和宣傳活動，擴大這些設備的普及範圍，幫助數百萬人更有效地管理自身病情，並減輕醫療系統的負擔。

自我監測血糖設備市場—關鍵洞察

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 11.53%

根據產品類型細分，自我監測血糖儀 (SMBG) 預計將在 2024 年佔據最大市場佔有率

根據技術細分，電化學技術是2024年的領先技術

根據測試站點細分，Fingertip 是 2024 年領先的測試站點

根據患者類型細分，2 型糖尿病是 2024 年的主要患者類型

根據最終用戶細分，家庭護理是 2024 年領先的最終用戶

按地區分類，北美是 2024 年的主要收入來源

自我監測血糖設備市場-細分分析：

全球自我監測血糖設備市場根據產品類型、技術、測試地點、患者類型、最終用戶和地區進行細分。

根據產品類型，市場分為四類：自我血糖儀 (SMBG)、試紙、採血針和連續血糖監測儀。自我血糖儀 (SMBG) 提供便捷的數位讀數追蹤，而試紙則確保準確性和快速結果。採血針對於採血至關重要，可最大程度地減少不適感。連續血糖監測儀能夠即時追蹤血糖，為更好的糖尿病管理提供了動力。

根據技術，市場分為兩類：電化學和光度法。電化學技術因其精確性、便攜性和成本效益而佔據主導地位，常用於SMBG設備。光度法技術雖然不太普及，但因其視覺清晰度和易於解讀而受到重視，常用於早期型號和特定的臨床應用。

自我監測血糖設備市場—地理洞察

自我監測血糖設備市場呈現出受醫療基礎設施、糖尿病盛行率和技術應用影響的區域動態。北美憑藉著先進的醫療體系和高糖尿病發病率領先，推動了對血糖監測設備的需求。緊隨其後的是歐洲，其特點是醫療政策健全且糖尿病患者數量眾多。由於糖尿病盛行率上升、醫療基礎設施改善以及糖尿病管理意識不斷提高，亞太地區正在經歷快速成長。中國、印度和日本等國家處於這一擴張的前沿。在醫療服務可近性改善和健康意識不斷提高的支持下，拉丁美洲、中東和非洲正在逐步採用這些技術。總體而言，市場的成長受到區域醫療保健優先事項、經濟狀況以及應對糖尿病相關健康挑戰的緊迫性的影響。

自我監測血糖設備市場-競爭格局：

自我監測血糖 (SMBG) 設備市場的特徵是老牌企業和新興創新企業之間的激烈競爭。雅培、Dexcom、羅氏診斷、LifeScan 和 Ascensia Diabetes Care 等領先公司憑藉其先進的技術和廣泛的分銷網路佔據了市場主導地位。雅培的 FreeStyle Libre 系列憑藉其感測器技術和經濟實惠的價格徹底改變了血糖監測領域，而 Dexcom 的 G6 和 G7 系統則以其準確性和方便用戶使用的設計而聞名。羅氏的 Accu-Chek 系列繼續成為許多人的信賴之選，注重可靠性以及與數位健康平台的整合。 LifeScan 的 OneTouch 產品設計簡潔、準確，可滿足廣泛的使用者群體。 Ascensia 的 Contour 系列以其可靠性和方便用戶使用的設計而聞名。市場也見證了新玩家的加入，例如 Ultrahuman，該公司推出了其連續血糖監測儀 Ultrahuman M1，目標客戶既包括運動員，也包括注重健康的消費者。策略合作、技術進步以及以使用者為中心的設計是推動 SMBG 設備市場競爭和創新的關鍵因素。

最新動態：

2024年7月，羅氏公司旗下Accu-Chek SmartGuide®連續血糖監測(CGM)設備取得CE標誌。該設備專為1型和2型糖尿病成人患者設計，提供即時血糖讀數和AI驅動的預測警報，以改善患者自我管理。

2024 年 5 月，Intuity Medical 和 embecta 宣布商業合作，以擴大對 Intuity 的 POGO Automatic(R) 血糖監測系統的使用範圍，旨在增強全美患者的自我監測選項和糖尿病護理。

2023 年 4 月，安斯泰來與日本羅氏糖尿病護理公司合作開發和商業化以羅氏血糖監測設備和 BlueStar 數位健康平台為特色的綜合糖尿病自我管理解決方案，旨在改善日本的糖尿病護理。

目錄

第1章：自我監測血糖設備市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 自我監測血糖設備市場（按產品類型）
    • 自我監測血糖設備市場（按技術）
    • 自我監測血糖設備市場片段（按測試站點）
    • 自我監測血糖設備市場（按患者類型）
    • 自我監測血糖設備市場（按最終用戶）
    • 自我監測血糖設備市場（按國家/地區）
    • 自我監測血糖設備市場（按地區）
  • 競爭洞察

第3章：自我監測血糖設備的主要市場趨勢

  • 自我監測血糖設備的市場促進因素
    • 市場促進因素的影響分析
  • 自我監測血糖儀市場限制
    • 市場限制的影響分析
  • 自我監測血糖設備的市場機遇
  • 自我監測血糖設備市場未來趨勢

第4章：自我監測血糖設備產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：自我監測血糖設備市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：自我監測血糖設備市場格局

  • 2024年自我監測血糖設備市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：自我監測血糖設備市場－依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 自我監測血糖儀（SMBG）
    • 測試條
    • 刺血針
    • 連續血糖監測儀

第8章：自我監測血糖設備市場 - 依技術

  • 概述
    • 按技術細分的市場佔有率分析
    • 電化學
    • 光度測定

第9章：自我監測血糖設備市場－按測試地點

  • 概述
    • 按測試站點進行細分佔有率分析
    • 指尖
    • 備用站點測試

第10章：自我監測血糖設備市場－依病患類型

  • 概述
    • 按患者類型進行細分佔有率分析
    • 1型糖尿病
    • 2型糖尿病
    • 妊娠糖尿病

第 11 章：自我監測血糖設備市場 - 按下最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院
    • 門診手術中心
    • 診斷中心
    • 居家護理
    • 其他

第 12 章：自我監測血糖設備市場 - 按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美自我監測血糖設備主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模及預測（按測試地點）
    • 北美市場規模及預測（依患者類型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲自我監測血糖設備主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模及預測（按測試地點）
    • 歐洲市場規模及預測（依患者類型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區自我監測血糖設備主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品類型）
    • 亞太地區市場規模及預測（依技術）
    • 亞太地區市場規模及預測（依測試地點分類）
    • 亞太地區市場規模及預測（依患者類型）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲自我監測血糖設備主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依產品類型）
    • 拉丁美洲市場規模及預測（按技術）
    • 拉丁美洲市場規模及預測（按測試站點）
    • 拉丁美洲市場規模及預測（按患者類型）
    • LATAM 規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲自我監測血糖設備主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按測試地點分類）
    • 中東和非洲市場規模及預測（按患者類型）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 13 章：主要供應商分析-自我監測血糖設備產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Abbott Laboratories
    • Acon Laboratories, Inc.
    • ARKRAY, Inc.
    • Ascensia Diabetes Care
    • B. Braun Melsungen AG
    • Bayer AG
    • Dexcom, Inc.
    • Eli Lilly and Company
    • GlucoMe
    • i-SENS, Inc.
    • LifeScan, Inc.
    • Medtronic plc
    • Nipro Corporation
    • Nova Biomedical
    • PHC Holdings Corporation
    • Roche Diagnostics
    • Sanofi
    • Terumo Corporation
    • Trividia Health, Inc.
    • Ypsomed Holding AG

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5438

REPORT HIGHLIGHT

Self-monitoring Blood Glucose Devices Market size was valued at US$ 19,752.01 Million in 2024, expanding at a CAGR of 11.53% from 2025 to 2032.

The Self-monitoring Blood Glucose Devices Market involves portable devices that enable individuals to measure their blood glucose levels independently, playing a crucial role in diabetes management worldwide. Rising diabetes prevalence and increasing awareness about self-care practices are expanding the demand for these devices. According to the World Health Organization, over 422 million people globally are affected by diabetes, emphasizing the importance of regular glucose monitoring. However, challenges such as high costs of advanced devices and limited accessibility in low-income regions can hinder widespread adoption. Opportunities lie in technological advancements like continuous glucose monitoring integration, non-invasive sensors, and smartphone connectivity, which improve user experience and data accuracy. Additionally, growing government initiatives promoting diabetes screening and management are enhancing market penetration, especially in developing countries where early diagnosis and consistent monitoring can significantly improve patient outcomes.

Self-monitoring Blood Glucose Devices Market- Market Dynamics

Rising diabetes prevalence and tech innovations to boost self-monitoring glucose device demand

Rising diabetes prevalence combined with rapid technological innovations is driving greater adoption of self-monitoring blood glucose devices globally. The International Diabetes Federation reports that approximately 1 in 10 adults worldwide lives with diabetes, underscoring the urgent need for effective self-care tools. Advances such as non-invasive sensors and mobile app integration are making glucose monitoring more convenient and accurate. The U.S. Centers for Disease Control and Prevention (CDC) emphasizes that regular blood glucose monitoring can significantly reduce complications and improve quality of life for diabetic patients. Furthermore, government health programs in countries like India and Brazil are increasing access to these devices through subsidies and awareness campaigns, helping millions manage their condition more effectively and reducing the burden on healthcare systems.

Self-monitoring Blood Glucose Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.53% over the forecast period (2025-2032)

Based on product type segmentation, Self-Monitoring Blood Glucose (SMBG) Meters were predicted to show maximum market share in the year 2024

Based on Technology segmentation, Electrochemical technology was the leading Technology in 2024

Based on Testing Site segmentation, Fingertip was the leading Testing Site in 2024

Based on Patient Type segmentation, Type 2 Diabetes was the leading Patient Type in 2024

Based on end user segmentation, Home Care was the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Self-monitoring Blood Glucose Devices Market- Segmentation Analysis:

The Global Self-monitoring Blood Glucose Devices Market is segmented on the basis of Product Type, Technology, Testing Site, Patient Type, End User, and Region.

The market is divided into four categories based on product type: Self-Monitoring Blood Glucose (SMBG) Meters, Test Strips, Lancets, and Continuous Glucose Monitors. Self-Monitoring Blood Glucose (SMBG) Meters offer convenient tracking with digital readings, while Test Strips ensure accuracy and quick results. Lancets are vital for blood sampling, offering minimal discomfort. Continuous Glucose Monitors enable real-time glucose tracking, gaining traction for better diabetes management.

The market is divided into two categories based on Technology: Electrochemical and Photometric. Electrochemical technology dominates due to its precision, portability, and cost-effectiveness, commonly used in SMBG devices. Photometric technology, though less prevalent, is valued for its visual clarity and ease of interpretation, often utilized in earlier models and specific clinical applications.

Self-monitoring Blood Glucose Devices Market- Geographical Insights

The Self-Monitoring Blood Glucose Devices Market exhibits regional dynamics influenced by healthcare infrastructure, diabetes prevalence, and technological adoption. North America leads with advanced healthcare systems and high diabetes rates, driving demand for glucose monitoring devices. Europe follows, characterized by robust healthcare policies and a significant diabetic population. The Asia-Pacific region is experiencing rapid growth due to increasing diabetes prevalence, improving healthcare infrastructure, and rising awareness about diabetes management. Countries like China, India, and Japan are at the forefront of this expansion. Latin America and the Middle East & and Africa are gradually adopting these technologies, supported by improving healthcare access and rising health awareness. Overall, the market's growth is shaped by regional healthcare priorities, economic conditions, and the urgency of addressing diabetes-related health challenges.

Self-monitoring Blood Glucose Devices Market- Competitive Landscape:

The Self-Monitoring Blood Glucose (SMBG) Devices Market is characterized by intense competition among established players and emerging innovators. Leading companies such as Abbott Laboratories, Dexcom, Roche Diagnostics, LifeScan, and Ascensia Diabetes Care dominate the market with their advanced technologies and extensive distribution networks. Abbott's FreeStyle Libre series has revolutionized glucose monitoring with its sensor technology and affordability, while Dexcom's G6 and G7 systems are renowned for their accuracy and user-friendly design. Roche's Accu-Chek line continues to be a trusted choice for many, emphasizing reliability and integration with digital health platforms. LifeScan's OneTouch products are designed for simplicity and accuracy, catering to a broad user base. Ascensia's Contour series is known for its reliability and user-friendly design. The market is also witnessing the entry of new players like Ultrahuman, which launched its continuous glucose monitor, Ultrahuman M1, targeting both athletes and health-conscious consumers. Strategic collaborations, technological advancements, and a focus on user-centric designs are key factors driving competition and innovation in the SMBG devices market.

Recent Developments:

In July 2024, Roche received CE Mark for its Accu-Chek SmartGuide(R) continuous glucose monitoring (CGM) device. Designed for adults with type 1 and type 2 diabetes, it offers real-time glucose readings and AI-powered predictive alerts for improved self-management.

In May 2024, Intuity Medical and embecta have announced a commercial collaboration to expand access to Intuity's POGO Automatic(R) Blood Glucose Monitoring System, aiming to enhance self-monitoring options and diabetes care for patients across the United States.

In April 2023, Astellas and Roche Diabetes Care Japan partnered to develop and commercialize an integrated diabetes self-management solution featuring Roche's blood glucose monitoring devices and the BlueStar digital health platform, aiming to improve diabetes care in Japan.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care
  • B. Braun Melsungen AG
  • Bayer AG
  • Dexcom, Inc.
  • Eli Lilly and Company
  • GlucoMe
  • i-SENS, Inc.
  • LifeScan, Inc.
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical
  • PHC Holdings Corporation
  • Roche Diagnostics
  • Sanofi
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Self-Monitoring Blood Glucose (SMBG) Meters
  • Test Strips
  • Lancets
  • Continuous Glucose Monitors

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Electrochemical
  • Photometric

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY TESTING SITE- MARKET ANALYSIS, 2019 - 2032

  • Fingertip
  • Alternate Site Testing

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostics Center
  • Home Care
  • Other

GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Self-monitoring Blood Glucose Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Self-monitoring Blood Glucose Devices Market Snippet by Product Type
    • 2.1.2. Self-monitoring Blood Glucose Devices Market Snippet by Technology
    • 2.1.3. Self-monitoring Blood Glucose Devices Market Snippet by Testing Site
    • 2.1.4. Self-monitoring Blood Glucose Devices Market Snippet by Patient Type
    • 2.1.5. Self-monitoring Blood Glucose Devices Market Snippet by End User
    • 2.1.6. Self-monitoring Blood Glucose Devices Market Snippet by Country
    • 2.1.7. Self-monitoring Blood Glucose Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Self-monitoring Blood Glucose Devices Key Market Trends

  • 3.1. Self-monitoring Blood Glucose Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Self-monitoring Blood Glucose Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Self-monitoring Blood Glucose Devices Market Opportunities
  • 3.4. Self-monitoring Blood Glucose Devices Market Future Trends

4. Self-monitoring Blood Glucose Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Self-monitoring Blood Glucose Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Self-monitoring Blood Glucose Devices Market Landscape

  • 6.1. Self-monitoring Blood Glucose Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Self-monitoring Blood Glucose Devices Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Self-Monitoring Blood Glucose (SMBG) Meters
    • 7.1.3. Test Strips
    • 7.1.4. Lancets
    • 7.1.5. Continuous Glucose Monitors

8. Self-monitoring Blood Glucose Devices Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Electrochemical
    • 8.1.3. Photometric

9. Self-monitoring Blood Glucose Devices Market - By Testing Site

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Testing Site, 2024 & 2032 (%)
    • 9.1.2. Fingertip
    • 9.1.3. Alternate Site Testing

10. Self-monitoring Blood Glucose Devices Market - By Patient Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Patient Type, 2024 & 2032 (%)
    • 10.1.2. Type 1 Diabetes
    • 10.1.3. Type 2 Diabetes
    • 10.1.4. Gestational Diabetes

11. Self-monitoring Blood Glucose Devices Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Ambulatory Surgery Centers
    • 11.1.4. Diagnostics Center
    • 11.1.5. Home Care
    • 11.1.6. Other

12. Self-monitoring Blood Glucose Devices Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Self-monitoring Blood Glucose Devices Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Self-monitoring Blood Glucose Devices Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Testing Site, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Self-monitoring Blood Glucose Devices Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. Acon Laboratories, Inc.
    • 13.2.3. ARKRAY, Inc.
    • 13.2.4. Ascensia Diabetes Care
    • 13.2.5. B. Braun Melsungen AG
    • 13.2.6. Bayer AG
    • 13.2.7. Dexcom, Inc.
    • 13.2.8. Eli Lilly and Company
    • 13.2.9. GlucoMe
    • 13.2.10. i-SENS, Inc.
    • 13.2.11. LifeScan, Inc.
    • 13.2.12. Medtronic plc
    • 13.2.13. Nipro Corporation
    • 13.2.14. Nova Biomedical
    • 13.2.15. PHC Holdings Corporation
    • 13.2.16. Roche Diagnostics
    • 13.2.17. Sanofi
    • 13.2.18. Terumo Corporation
    • 13.2.19. Trividia Health, Inc.
    • 13.2.20. Ypsomed Holding AG

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us